thiazoles has been researched along with Astrocytoma, Grade IV in 81 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (7.41) | 18.2507 |
| 2000's | 24 (29.63) | 29.6817 |
| 2010's | 43 (53.09) | 24.3611 |
| 2020's | 8 (9.88) | 2.80 |
| Authors | Studies |
|---|---|
| Cherniienko, A; Finiuk, N; Klyuchivska, O; Lesyk, R; Lozynskyi, A; Manko, N; Senkiv, J; Stoika, R; Yushyn, I; Zelisko, N | 1 |
| Cai, SZ; Ma, ZR; Shi, L; Sun, X; Zhao, W | 1 |
| Bradshaw, TD; Lewis, W; Moody, CJ; Stevens, MFG; Summers, HS; Williams, HEL | 1 |
| Allegro, D; Barbier, P; Breuzard, G; DiMaio, A; Hedna, R; Kovacic, H; Peyrot, V; Robin, M; Tatoni, M | 1 |
| Caligiuri, MA; Chao, S; Dai, H; Glorioso, JC; Hurwitz, B; Jaime-Ramirez, AC; Kaur, B; Lee, TJ; Liu, J; Otani, Y; Yan, Y; Yoo, JY; Yu, J | 1 |
| Al-Awadhi, FH; Chen, QY; Elsadek, LA; Luesch, H; Ratnayake, R; Salvador-Reyes, LA | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Ardakani, YH; Dinarvand, R; Rezaei, M; Shirazi, AS; Varshochian, R | 1 |
| Colapietro, A; Di Cesare, E; Festuccia, C; Fox, JA; Gravina, GL; Mancini, A; Marampon, F; Mattei, C; Rossi, G; Ventura, L; Vetuschi, A; Vitale, F | 1 |
| Chen, L; Hai, L; Huang, Y; Jiang, T; Li, S; Li, T; Lin, Y; Liu, B; Ming, H; Ren, B; Yang, X; Yu, S; Zhang, C; Zhang, K; Zhao, P; Zhou, H; Zhou, X; Zhu, M | 1 |
| Ai, C; Dong, F; Kang, C; Kong, Y; Sun, X; Wu, X; Xia, X; Yang, C; Zhao, Q; Zhao, X; Zhou, Y | 1 |
| Lee, C; Robinson, M; Willerth, SM | 1 |
| Abbosh, C; Allison, SJ; Ballereau, S; Beard, HA; Bon, RS; Chumas, P; Chuntharpursat-Bon, E; da Silva, B; Davies, AJ; Droop, A; Gestwicki, JE; Griffiths, HBS; Holding, AN; Kuchler, VB; Lorger, M; Markowetz, F; Mathew, RK; Patel, A; Polson, ES; Roberts, LD; Ross, EM; Shao, H; Short, SC; Williams, J; Wurdak, H; Zhu, S | 1 |
| Babsky, A; Finiuk, N; Hreniukh, V; Ivasechko, I; Klyuchivska, O; Matiychuk, V; Obushak, M; Ostapiuk, Y; Panchuk, R; Shalai, Y; Stoika, R | 1 |
| Beberok, A; Buszman, E; Respondek, M; Rok, J; Rzepka, Z; Wrześniok, D | 1 |
| Abou-El-Ardat, K; Fulda, S; Kögel, D; Mari, M; Meyer, N; Reggiori, F; van Wijk, SJL; Zielke, S | 1 |
| Chen, X; Han, D; Hou, X; Liu, H; Liu, Z; Ma, J; Peng, F; Shen, C; Shu, M; Wang, K; Wang, L; Wang, X; Wu, J; Yang, G; Yin, Z; Zhang, D; Zhao, B; Zhao, S; Zhao, W; Zheng, Z; Zhong, C | 1 |
| Cao, L; Chen, J; Hu, J; Lin, J; Lin, S; Mao, L; Ouyang, Y; Yan, G; Yang, X; Zhang, H; Zhou, Y; Zhu, W | 1 |
| Abounader, R; Dominguez, CL; Floyd, DH; Harris, TE; Kefas, BA; Lee, JK; Mullins, GR; Purow, BW; Wilson, GM; Xiao, A; Xin, W; Yacur, MN | 1 |
| Krueger, SA; Marignol, L; Marples, B; Martin, L; Schoenherr, D; Wilson, GD | 1 |
| Alexis, F; Grimes, SW; Lewis, RL; Moore, TL | 1 |
| Cao, S; Gao, H; Jiang, X; Pang, Z; Yang, Z; Zhang, S | 1 |
| Cho, JM; Choi, SW; Hong, IS; Kang, KS; Kang, TW; Kim, HS; Ro, S; Shin, TH; Yang, SR; Yu, KR | 1 |
| Efferth, T; Frewert, S; Hamm, R; Zeino, M | 1 |
| Green, AL; Hsu, JH; Hubbell-Engler, B; Jones, K; Knoff, DS; Kung, AL; Ligon, KL; Maire, CL; McCauley, D; Perry, JA; Ramkissoon, LA; Ramkissoon, SH; Shacham, S | 1 |
| Firouzi, F; Khoei, S; Mirzaei, HR | 1 |
| Cheng, J; He, JQ; Kang, B; Li, WX; Tong, Y; Wang, YJ; Yang, Y; Yao, HP; Yin, SY; Zhang, XQ; Zhao, QW; Zheng, M; Zhou, YW | 1 |
| Fukami, T; Fukuda, M; Hojo, M; Inubushi, T; Miyamoto, S; Muraki, K; Nozaki, K; Onishi, N; Saiki, M; Satow, T; Saya, H; Shiino, A; Tanigaki, K; Yamada, S; Yoshimura, Y | 1 |
| Alain, T; Beauregard, CE; Beug, ST; Chabot, J; Earl, N; Forsyth, PA; Healy, C; Korneluk, RG; LaCasse, EC; Lun, X; Mohan, A; Robbins, SM; Sanda, T; Senger, DL; St-Jean, M; Staeheli, P; Walker, DE | 1 |
| Jan, HJ; Lee, CC; Lee, HM; Lin, YM; Shih, YL; Tao, HY; Wei, HW | 1 |
| Cambar, J; De Giorgi, F; Ichas, F; L'Azou, B; Passagne, I; Pédeboscq, S; Pometan, JP | 1 |
| Bernasconi, P; Beroukhim, R; Burns, M; Carr, SA; Clauser, KR; Du, J; Finn, SP; Golub, TR; Hieronymus, H; Julian, B; Kung, AL; Lewis, TA; Liau, LM; Loda, M; Louis, DN; Maglathlin, RL; Mani, DR; Mellinghoff, IK; Nghiemphu, P; Peng, XP | 1 |
| Fujisawa, H; Hamada, J; Hayashi, Y; Kawakami, K; Mai, W; Minamoto, T; Miyashita, K; Nakada, M; Shakoori, A | 1 |
| Ali, MA; Chattopadhyay, A; Ding, LH; Habib, AA; Reis, A; Saha, D; Story, MD | 1 |
| Czernin, JG; Dumont, RA; Haubner, R; Hildebrandt, I; Mischel, PS; Reischl, G; Su, H; Weber, WA | 1 |
| Johnson, C; Johnson, S; Lu, D; Ou, XM; Stockmeier, CA; Tazik, S; Youdim, MB | 1 |
| de Groot, J; Milano, V | 1 |
| Cao, X; Li, XM; Mousseau, DD | 1 |
| Bektas, M; Bigner, DD; Friedman, HS; Johnson, SP; Poe, WE | 1 |
| Facoetti, A; Mazzini, G; Nano, R; Ranza, E | 1 |
| Ahkavan, D; Bergers, G; Caldwell, JS; Cavenee, WK; Chakravari, A; Chen, Z; Cloughesy, TF; Cvrljevic, A; Dang, J; Dinca, EB; Furnari, FB; Graeber, T; Huang, TT; James, CD; Johns, TG; Lee, FY; Lee, Y; Loo, JA; Lu, KV; Mischel, PS; Nelson, SF; Oderberg, I; Plaisier, SB; Sarkaria, S; Seligson, D; Weinmann, R; Xie, Y; Zhu, S | 1 |
| Ayuso-Sacido, A; Boockvar, JA; García-Verdugo, JM; Holland, EC; Kapoor, GS; Kratovac, S; Moliterno, JA; O'Rourke, DM; Roy, NS | 1 |
| Han, L; Jia, ZF; Kang, CS; Mei, M; Pu, PY; Ren, Y; Wang, GX; Xu, P; Yuan, XB; Zhou, X | 1 |
| Hu, W; Liu, W | 1 |
| Cambar, J; De Giorgi, F; Ichas, F; L'Azou, B; Liguoro, D; Passagne, I; Pédeboscq, S; Pometan, JP | 1 |
| Jane, EP; Pollack, IF; Premkumar, DR | 1 |
| Ahluwalia, MS; de Groot, J; Gladson, CL; Liu, WM | 1 |
| Beroukhim, R; Ciampa, AS; Doherty, LM; Drappatz, J; Lafrankie, DC; Lu-Emerson, C; Norden, AD; Quant, EC; Ruland, S; Wen, PY | 1 |
| Fan, Y; Wang, Y; Wu, A; Zhang, X | 1 |
| Clavreul, A; Huynh, NT; Menei, P; Montero-Menei, C; Passirani, C; Roger, M; Schiller, P; Vessières, A | 1 |
| Bo, Y; Li, S; Meng, Q; Sun, X; Wang, C; Wang, J; Yao, W | 1 |
| Babu, PP; Geeviman, K; Ramulu, C; Sareddy, GR | 1 |
| Akhavan, D; Cavenee, WK; Cvrljevic, AN; Furnari, FB; Guo, D; Hoogenraad, NJ; Johns, TG; Johnston, AJ; Martinello, P; Mischel, PS; Pike, L; Scott, AM; Wu, M | 1 |
| Ang, FY; Fukuzaki, Y; Kogure, S; Yamanoha, B | 1 |
| Amini, S; Bookland, MJ; Darbinian, N; Khalili, K; Weaver, M | 1 |
| Chung, SP; Diem, TH; El Sayed, SM; El-Magd, RM; Fukui, K; Kagami, S; Sakai, T; Shishido, Y; Watanabe, H | 1 |
| Cheng, HC; Kuo, HC; Sze, CI; Teng, CC; Wang, TC | 1 |
| Brilli, E; Caldera, V; Cattaneo, E; Conforti, P; Conti, L; Crisafulli, L; Magrassi, L; Schiffer, D; Tortoreto, M; Zunino, F | 1 |
| Guo, D; Hou, L; Mao, P; Mo, L; Xiao, X; Yang, X | 1 |
| Agarwal, S; Decker, SA; Donelson, R; Elmquist, WF; Gallardo, JL; Mittapalli, RK; Ohlfest, JR; Pokorny, JL; Santacruz, KS; Sarkaria, JN; Seiler, C; Zellmer, DM | 1 |
| Greca, R; Rizzarelli, E; Satriano, C; Scalia, M; Spina-Purrello, V; Stella, AM | 1 |
| Allgeier, A; Brandes, AA; Franceschi, E; Gorlia, T; Hegi, M; Lacombe, D; Laigle Donadey, F; Lhermitte, B; Strauss, LC; Stupp, R; van den Bent, MJ; van Herpen, C | 1 |
| Benezra, M; Bradbury, MS; Hambardzumyan, D; Holland, EC; Larson, SM; Longo, V; Ozawa, T; Penate-Medina, O; Phillips, E; Pillarsetty, N; Smith-Jones, P; Veach, DR; Zanzonico, PB | 1 |
| Broaddus, WC; Dent, P; Fisher, PB; Gopalkrishnan, RV; Grant, S; Lebedeva, IV; Lister, A; McKinstry, R; Mitchell, C; Qiao, L; Ramakrishnan, V; Sarkar, D; Sigmon, C; Su, ZZ; Yacoub, A | 1 |
| Kitai, R; Kubota, T; Matsukawa, S; Sato, K; Takeuchi, H; Yao, Y | 1 |
| Bansal, S; Chandra, R; Kasi Sankar, V; Singh, J; Tandon, V; Tiwari, RK; Verma, AK | 1 |
| Ali, MA; Choy, H; Habib, AA; Saha, D | 1 |
| Bian, XW; Chen, DL; Chen, JH; Ping, YF; Wang, JM; Xu, CP; Yao, XH; Zheng, J | 1 |
| Balachandran, R; Day, BW; McPherson, PA; Raccor, BS; Vogt, A; Wang, Z; Wipf, P; Zhu, G | 1 |
| Chan, DY; Chen, GG; Liu, PC; Poon, WS | 1 |
| Blanco, G; Debeir, O; Gailly, P; Kiss, R; Kondo, S; Kondo, Y; Krstic, D; Lefranc, F; Mijatovic, T; Roland, I; Sauvage, S; Vasic, V | 1 |
| Itokawa, Y; Kikuchi, H; Kimura, M; Nakatsu, S; Oda, Y; Zhu, Z | 1 |
| Fujita, H; Hotta, T; Ikenaga, M; Ishizaki, K; Isowa, G; Kiya, K; Kurisu, K; Mikami, T; Saito, Y; Uozumi, T | 1 |
| Damian, MS; Leweke, F; Schachenmayr, W; Schindler, C | 1 |
| Galla, HJ; Poppenborg, H; Wolff, JE | 1 |
| Anderson, R; Krebs, B; Pascha, KP; Poppenborg, H; Thulig, CC; Wolff, JE | 1 |
| Bouvet, M; Chiocca, EA; Eling, DJ; Gilpin, E; Kipps, TJ; Spear, MA; Sun, F | 1 |
| Albajar, M; Galetto, R; Polanco, JI; Rodríguez-Rey, JC; Zakin, MM | 1 |
| Dixon, JE; Donner, DB; Durden, DL; Mayo, LD; Tonks, NK | 1 |
| Fujieda, M; Kato, M; Nagaya, T; Saito, K; Seo, H; Yoshida, J | 1 |
| Black, P; Hand, CM; Jordan, JP; Markowitz, RS | 1 |
3 review(s) available for thiazoles and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Improving the prognosis for patients with glioblastoma: the rationale for targeting Src.
Topics: Brain Neoplasms; Dasatinib; Glioblastoma; Humans; Prognosis; Protein Kinase Inhibitors; Pyrimidines; src-Family Kinases; Thiazoles | 2009 |
Targeting SRC in glioblastoma tumors and brain metastases: rationale and preclinical studies.
Topics: Brain Neoplasms; Cell Proliferation; Dasatinib; Glioblastoma; Humans; Models, Biological; Protein Kinase Inhibitors; Proto-Oncogene Proteins pp60(c-src); Pyrimidines; Signal Transduction; src-Family Kinases; Thiazoles | 2010 |
2 trial(s) available for thiazoles and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dasatinib; Disease-Free Survival; Female; Glioblastoma; Humans; Lomustine; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Pyrimidines; Thiazoles | 2012 |
77 other study(ies) available for thiazoles and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Thiopyrano[2,3-d]thiazole structures as promising scaffold with anticancer potential.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Glioblastoma; HEK293 Cells; Humans; Leukemia; Mammals; Mice; Reactive Oxygen Species; Thiazoles | 2022 |
Discovery of novel analogs of KHS101 as transforming acidic coiled coil containing protein 3 (TACC3) inhibitors for the treatment of glioblastoma.
Topics: Cell Cycle Proteins; Glioblastoma; Humans; Microtubule-Associated Proteins; Thiazoles | 2022 |
Discovery of new imidazotetrazinones with potential to overcome tumor resistance.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Drug Resistance, Neoplasm; Glioblastoma; Humans; Temozolomide; Thiazoles | 2023 |
2-Aminothiazole-Flavonoid Hybrid Derivatives Binding to Tau Protein and Responsible for Antitumor Activity in Glioblastoma.
Topics: Glioblastoma; Humans; Microtubules; Protein Binding; tau Proteins; Thiazoles; Tubulin | 2023 |
Oncolytic HSV-Infected Glioma Cells Activate NOTCH in Adjacent Tumor Cells Sensitizing Tumors to Gamma Secretase Inhibition.
Topics: Amyloid Precursor Protein Secretases; Animals; Benzazepines; Brain Neoplasms; Cell Line, Tumor; Diamines; Female; Glioblastoma; Herpesvirus 1, Human; Humans; Male; Mice; Mice, Nude; MicroRNAs; Mixed Function Oxygenases; Oncolytic Virotherapy; Random Allocation; Receptors, Notch; Repressor Proteins; Signal Transduction; Thiazoles; Ubiquitin-Protein Ligases; Xenograft Model Antitumor Assays | 2020 |
Largazole is a Brain-Penetrant Class I HDAC Inhibitor with Extended Applicability to Glioblastoma and CNS Diseases.
Topics: Animals; Brain; Cell Line, Tumor; Central Nervous System Diseases; Depsipeptides; Glioblastoma; Histone Deacetylase Inhibitors; Mice; Thiazoles | 2020 |
SN38 loaded nanostructured lipid carriers (NLCs); preparation and in vitro evaluations against glioblastoma.
Topics: Calorimetry, Differential Scanning; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Liberation; Drug Screening Assays, Antitumor; Excipients; Glioblastoma; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Irinotecan; Lipids; Microscopy, Confocal; Nanoparticles; Nanostructures; Particle Size; Solubility; Solvents; Tetrazolium Salts; Thiazoles | 2021 |
Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers; Cell Line, Tumor; Cell Survival; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Evaluation, Preclinical; Female; Glioblastoma; Humans; Leukocytes; Mice; Naphthyridines; Necrosis; Radiation Tolerance; Survival Rate; Thiazoles; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |
Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-κB(p65) pathway.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diamines; Glioblastoma; Humans; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Prognosis; Receptor, Notch1; Signal Transduction; Spheroids, Cellular; Survival Analysis; Thiazoles; Transcription Factor RelA | 2018 |
Targeting of BMI-1 with PTC-209 inhibits glioblastoma development.
Topics: Animals; Brain Neoplasms; Carcinogenesis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Self Renewal; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Glioblastoma; Heterocyclic Compounds, 2-Ring; Humans; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Neoplastic Stem Cells; Polycomb Repressive Complex 1; Promoter Regions, Genetic; RNA, Messenger; Thiazoles; Transcription, Genetic; Up-Regulation | 2018 |
Direct Reprogramming of Glioblastoma Cells into Neurons Using Small Molecules.
Topics: Basic Helix-Loop-Helix Transcription Factors; Brain Neoplasms; Cell Line, Tumor; Cellular Reprogramming; Cellular Reprogramming Techniques; Colforsin; Diamines; Glioblastoma; Heterocyclic Compounds, 4 or More Rings; Homeodomain Proteins; Humans; Isoxazoles; Microtubule-Associated Proteins; Nerve Tissue Proteins; Neurons; POU Domain Factors; Pyridines; Pyrimidines; Thiazoles; Thiophenes; Up-Regulation | 2018 |
KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in mice.
Topics: Animals; Apoptosis; Autophagy; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Chaperonin 60; Citric Acid Cycle; Disease Models, Animal; Energy Metabolism; Glioblastoma; Glycolysis; Humans; Metabolic Networks and Pathways; Mitochondria; Mitochondrial Proteins; Neoplasm Invasiveness; Stress, Physiological; Survival Analysis; Thiazoles; Transcription, Genetic; Xenograft Model Antitumor Assays | 2018 |
Proapoptotic effects of novel thiazole derivative on human glioma cells.
Topics: Antineoplastic Agents; Apoptosis; Benzofurans; Brain Neoplasms; Cell Line, Tumor; DNA Damage; Doxorubicin; Glioblastoma; Humans; Inhibitory Concentration 50; Intercalating Agents; Reactive Oxygen Species; Temozolomide; Thiazoles | 2019 |
MIM1, the Mcl-1 - specific BH3 mimetic induces apoptosis in human U87MG glioblastoma cells.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; Dacarbazine; DNA Damage; Dose-Response Relationship, Drug; Glioblastoma; Humans; Membrane Potential, Mitochondrial; Myeloid Cell Leukemia Sequence 1 Protein; Temozolomide; Thiazoles | 2018 |
Loperamide, pimozide, and STF-62247 trigger autophagy-dependent cell death in glioblastoma cells.
Topics: Apoptosis; Autophagosomes; Autophagy; Brain Neoplasms; Cell Line, Tumor; Endosomes; Glioblastoma; HT29 Cells; Humans; Loperamide; Lysosomes; Mechanistic Target of Rapamycin Complex 1; Microscopy, Electron; Microtubule-Associated Proteins; Phosphorylation; Pimozide; Pyridines; Reactive Oxygen Species; Ribosomal Protein S6 Kinases; Thiazoles | 2018 |
Nitazoxanide, an antiprotozoal drug, inhibits late-stage autophagy and promotes ING1-induced cell cycle arrest in glioblastoma.
Topics: Animals; Antiprotozoal Agents; Apoptosis; Autophagy; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line; Cell Line, Tumor; Cell Proliferation; Chloroquine; Glioblastoma; Glioma; Human Umbilical Vein Endothelial Cells; Humans; Inhibitor of Growth Protein 1; Mice; Mice, Inbred BALB C; Mice, Nude; Naphthyridines; Nitro Compounds; Protein Processing, Post-Translational; Thiazoles; Transcription, Genetic; Up-Regulation | 2018 |
Diazepam inhibits proliferation of human glioblastoma cells through triggering a G0/G1 cell cycle arrest.
Topics: Antimetabolites; Benzimidazoles; Blotting, Western; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coloring Agents; Diazepam; Fluorescent Dyes; G1 Phase; G1 Phase Cell Cycle Checkpoints; GABA Modulators; Glioblastoma; Humans; L-Lactate Dehydrogenase; Resting Phase, Cell Cycle; S Phase; Tetrazolium Salts; Thiazoles | 2013 |
Diacylglycerol kinase α is a critical signaling node and novel therapeutic target in glioblastoma and other cancers.
Topics: Apoptosis; Brain Neoplasms; Cell Line, Tumor; Diacylglycerol Kinase; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Molecular Targeted Therapy; Piperidines; Pyrimidinones; Quinazolinones; RNA, Small Interfering; Thiazoles | 2013 |
Determining if low dose hyper-radiosensitivity (HRS) can be exploited to provide a therapeutic advantage: a cell line study in four glioblastoma multiforme (GBM) cell lines.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Damage; DNA Repair; Dose Fractionation, Radiation; G2 Phase Cell Cycle Checkpoints; Glioblastoma; Humans; Models, Theoretical; Radiation Tolerance; Tetrazolium Salts; Thiazoles; X-Rays | 2013 |
Multilayered polymer-coated carbon nanotubes to deliver dasatinib.
Topics: Cell Proliferation; Dasatinib; Drug Delivery Systems; Glioblastoma; Humans; Kinetics; Lactic Acid; Microscopy, Electron, Transmission; Nanoparticles; Nanotubes, Carbon; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymerization; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Thiazoles; Tumor Cells, Cultured | 2014 |
In vitro and in vivo intracellular distribution and anti-glioblastoma effects of docetaxel-loaded nanoparticles functioned with IL-13 peptide.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biological Transport; Brain Neoplasms; Cell Line, Tumor; Coumarins; Docetaxel; Drug Delivery Systems; Glioblastoma; Humans; Interleukin-13; Male; Mice, Inbred BALB C; Nanoparticles; Peptides; Taxoids; Thiazoles | 2014 |
Growth arrest and forced differentiation of human primary glioblastoma multiforme by a novel small molecule.
Topics: Aniline Compounds; Animals; Antineoplastic Agents; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Female; Glioblastoma; Humans; Mice, Inbred NOD; Mice, SCID; Signal Transduction; Spheroids, Cellular; Thiazoles; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2014 |
Up-regulation of cholesterol associated genes as novel resistance mechanism in glioblastoma cells in response to archazolid B.
Topics: Cell Line, Tumor; Cholesterol; Drug Resistance, Neoplasm; Glioblastoma; Humans; Macrolides; Thiazoles; Up-Regulation | 2014 |
Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastoma.
Topics: Acrylamides; Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Cycle Checkpoints; Cell Differentiation; Cell Line, Tumor; Dose-Response Relationship, Drug; Exportin 1 Protein; Glioblastoma; Humans; Hydrazines; Karyopherins; Macaca fascicularis; Male; Mice; Oxadiazoles; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Thiazoles; Treatment Outcome; Triazoles; Xenograft Model Antitumor Assays | 2015 |
Role of resveratrol on the cytotoxic effects and DNA damages of iododeoxyuridine and megavoltage radiation in spheroid culture of U87MG glioblastoma cell line.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Comet Assay; DNA Damage; Dose-Response Relationship, Drug; Glioblastoma; Humans; Idoxuridine; Resveratrol; Stilbenes; Tetrazolium Salts; Thiazoles; Trypan Blue; X-Rays | 2015 |
Akt‑mediated phosphorylation of Oct4 is associated with the proliferation of stem‑like cancer cells.
Topics: Animals; Benzylamines; Brain Neoplasms; Carcinoma, Hepatocellular; Cell Division; Cell Line, Tumor; Cell Nucleus; Culture Media; Glioblastoma; Heterografts; Humans; Indoles; Liver Neoplasms; Mice; Mice, Nude; Neoplasm Proteins; Neoplastic Stem Cells; Octamer Transcription Factor-3; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Quinoxalines; Receptors, Aryl Hydrocarbon; RNA Interference; RNA, Small Interfering; Signal Transduction; Spheroids, Cellular; Thiazoles | 2015 |
Arsenic trioxide sensitizes glioblastoma to a myc inhibitor.
Topics: Aged; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Brain Neoplasms; Cell Differentiation; Cell Proliferation; Disease Progression; ErbB Receptors; Female; Glioblastoma; Hedgehog Proteins; Humans; Magnetic Resonance Imaging; Male; Mice, SCID; Middle Aged; Neoplastic Stem Cells; Oxides; Proto-Oncogene Proteins c-myc; Signal Transduction; Thiazoles; Xenograft Model Antitumor Assays | 2015 |
Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma.
Topics: Adaptive Immunity; Animals; Antineoplastic Agents; B7-H1 Antigen; Brain Neoplasms; Cell Line, Tumor; Female; Gene Expression Regulation; Genetic Vectors; Glioblastoma; Humans; Immunity, Innate; Immunologic Memory; Inhibitor of Apoptosis Proteins; Interferon-alpha; Interferon-beta; Mice; Poly I-C; Signal Transduction; Survival Analysis; T-Lymphocytes, Cytotoxic; Thiazoles; Tumor Necrosis Factor-alpha; Vesiculovirus; Xenograft Model Antitumor Assays | 2017 |
Dexamethasone reduced invasiveness of human malignant glioblastoma cells through a MAPK phosphatase-1 (MKP-1) dependent mechanism.
Topics: Antineoplastic Agents, Hormonal; Blotting, Western; Cell Line, Tumor; Chorioallantoic Membrane; Collagen; Dexamethasone; Drug Combinations; Dual Specificity Phosphatase 1; Glioblastoma; Humans; Immunohistochemistry; Laminin; Mitogen-Activated Protein Kinase 1; Neoplasm Invasiveness; Nitric Oxide; Nitric Oxide Synthase Type II; Plasmids; Proteoglycans; Tetrazolium Salts; Thiazoles | 2008 |
Cytotoxic and apoptotic effects of bortezomib and gefitinib compared to alkylating agents on human glioblastoma cells.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Apoptosis; Boronic Acids; Bortezomib; Brain Neoplasms; Carboplatin; Carmustine; Cell Line, Tumor; Dacarbazine; Dose-Response Relationship, Drug; ErbB Receptors; Flow Cytometry; Gefitinib; Glial Fibrillary Acidic Protein; Glioblastoma; Immunohistochemistry; Indicators and Reagents; Mice; Proteasome Inhibitors; Pyrazines; Quinazolines; Rats; Temozolomide; Tetrazolium Salts; Thiazoles | 2008 |
Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy.
Topics: Animals; Biotechnology; Cell Line, Tumor; Dasatinib; Drug Resistance, Neoplasm; Genetic Techniques; Glioblastoma; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Phosphorylation; Protein-Tyrosine Kinases; Pyrimidines; src-Family Kinases; Thiazoles | 2009 |
Potential therapeutic effect of glycogen synthase kinase 3beta inhibition against human glioblastoma.
Topics: Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Evaluation, Preclinical; Glioblastoma; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Radiation-Sensitizing Agents; RNA Interference; Thiazoles; Urea | 2009 |
SNS-032 prevents hypoxia-mediated glioblastoma cell invasion by inhibiting hypoxia inducible factor-1alpha expression.
Topics: Antineoplastic Agents; Cell Line, Tumor; Collagen; Cyclooxygenase 2 Inhibitors; DNA Primers; Drug Combinations; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Laminin; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Oxazoles; Proteoglycans; RNA, Small Interfering; Thiazoles; Vascular Endothelial Growth Factor A | 2009 |
Noninvasive imaging of alphaVbeta3 function as a predictor of the antimigratory and antiproliferative effects of dasatinib.
Topics: Animals; Cell Growth Processes; Cell Line, Tumor; Cell Movement; Copper Radioisotopes; Dasatinib; Focal Adhesions; Glioblastoma; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Male; Mice; Mice, SCID; Oligopeptides; Organometallic Compounds; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrimidines; src-Family Kinases; Thiazoles | 2009 |
Comparative neuroprotective effects of rasagiline and aminoindan with selegiline on dexamethasone-induced brain cell apoptosis.
Topics: Analysis of Variance; Anti-Inflammatory Agents; Apoptosis; Brain; Cell Line, Tumor; Dexamethasone; Dose-Response Relationship, Drug; Glioblastoma; Humans; In Situ Nick-End Labeling; Indans; Monoamine Oxidase; Neuroblastoma; Neuroprotective Agents; Selegiline; Tetrazolium Salts; Thiazoles | 2009 |
Calcium alters monoamine oxidase-A parameters in human cerebellar and rat glial C6 cell extracts: possible influence by distinct signalling pathways.
Topics: Aged; Animals; Binding Sites; Calcium; Calcium Signaling; Cell Line, Tumor; Cerebellum; Gene Expression; Glioblastoma; Humans; Male; Mice; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroglia; Neurons; p38 Mitogen-Activated Protein Kinases; Protein Binding; Rats; RNA, Messenger; Thiazoles | 2009 |
A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cells.
Topics: Aniline Compounds; Antineoplastic Agents, Alkylating; Apoptosis; Caspase 3; Cell Death; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Drug Resistance, Neoplasm; Enzyme Inhibitors; Flow Cytometry; Glioblastoma; Humans; Indicator Dilution Techniques; Oligonucleotide Array Sequence Analysis; Phosphotransferases (Alcohol Group Acceptor); Reverse Transcriptase Polymerase Chain Reaction; Temozolomide; Thiazoles | 2009 |
In-vitro effects of the tyrosine kinase inhibitor imatinib on glioblastoma cell proliferation.
Topics: Apoptosis; Benzamides; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Size; Cell Survival; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Flow Cytometry; Glioblastoma; Humans; Imatinib Mesylate; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Tetrazolium Salts; Thiazoles | 2010 |
Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients.
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Cell Movement; Cell Survival; Central Nervous System Neoplasms; Dasatinib; Drug Synergism; Enzyme Activation; ErbB Receptors; Gene Silencing; Glioblastoma; Humans; Mice; Mutation; Neoplasm Invasiveness; Neoplasm Transplantation; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-fyn; Pyrimidines; Signal Transduction; src-Family Kinases; Thiazoles | 2009 |
Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells.
Topics: Animals; Animals, Newborn; Apoptosis; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Enzyme Inhibitors; ErbB Receptors; Gene Expression Regulation, Neoplastic; Glioblastoma; Green Fluorescent Proteins; Humans; Mutation; Nerve Tissue Proteins; Neurons; Oxidative Stress; Quinazolines; Signal Transduction; Stem Cells; Tetrazolium Salts; Thiazoles; Time Factors; Transfection; Tyrphostins | 2010 |
MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol.
Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; ErbB Receptors; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Inhibitory Concentration 50; MicroRNAs; Models, Biological; Paclitaxel; Phosphorylation; PTEN Phosphohydrolase; STAT3 Transcription Factor; Tetrazolium Salts; Thiazoles | 2010 |
Side populations of glioblastoma cells are less sensitive to HSV-TK/GCV suicide gene therapy system than the non-side population.
Topics: Antiviral Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line, Tumor; Flow Cytometry; Ganciclovir; Genes, Transgenic, Suicide; Genetic Therapy; Genetic Vectors; Glioblastoma; Humans; Neoplasm Proteins; Simplexvirus; Tetrazolium Salts; Thiazoles; Thymidine Kinase | 2010 |
Anticancer drugs exert differential apoptotic and cytotoxic effects on glioblastoma primary cultures with various EGFR and bcl-2 profiles.
Topics: Adult; Aged; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cells, Cultured; Coloring Agents; ErbB Receptors; Flow Cytometry; Genes, bcl-2; Glial Fibrillary Acidic Protein; Glioblastoma; Humans; Immunohistochemistry; Middle Aged; Tetrazolium Salts; Thiazoles | 2009 |
Co-administration of NVP-AEW541 and dasatinib induces mitochondrial-mediated apoptosis through Bax activation in malignant human glioma cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Cell Cycle; Cell Cycle Proteins; Cell Growth Processes; Cell Line, Tumor; Dasatinib; Drug Synergism; Fluorescent Antibody Technique; Glioblastoma; Humans; Mitochondria; Phosphorylation; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Signal Transduction; Thiazoles; Transfection | 2010 |
Retrospective study of dasatinib for recurrent glioblastoma after bevacizumab failure.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neoplasms; Dasatinib; Female; Glioblastoma; Humans; Male; Middle Aged; Protein Kinase Inhibitors; Pyrimidines; Retrospective Studies; Thiazoles | 2011 |
Increased transforming growth factor-β2 in epidermal growth factor receptor variant III-positive glioblastoma.
Topics: Adult; Aged; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Interleukin-10; Male; Middle Aged; Neoplasm Invasiveness; RNA, Messenger; Sequence Deletion; Tetrazolium Salts; Thiazoles; Transfection; Transforming Growth Factor beta2 | 2011 |
Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coculture Techniques; Coumarins; Drug Delivery Systems; Female; Ferrous Compounds; Glioblastoma; Humans; Injections, Intralesional; Lipids; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Nude; Nanocapsules; Particle Size; Plant Lectins; Polyethylene Glycols; Soybean Proteins; Static Electricity; Stearic Acids; Thiazoles; Treatment Outcome; Triglycerides; Xenograft Model Antitumor Assays | 2012 |
siRNA targeting Notch-1 decreases glioma stem cell proliferation and tumor growth.
Topics: Analysis of Variance; Animals; Blotting, Western; Cell Proliferation; Fluorescent Antibody Technique; Gene Expression Regulation; Glioblastoma; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Real-Time Polymerase Chain Reaction; Receptor, Notch1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Signal Transduction; Tetrazolium Salts; Thiazoles; Transfection | 2012 |
The nonsteroidal anti-inflammatory drug celecoxib suppresses the growth and induces apoptosis of human glioblastoma cells via the NF-κB pathway.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Blotting, Western; Brain Neoplasms; Celecoxib; Cell Line, Tumor; Cell Nucleus; Cell Survival; Colony-Forming Units Assay; Coloring Agents; Cyclooxygenase 2 Inhibitors; Cytosol; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; Fluorescent Antibody Technique; Glioblastoma; Humans; I-kappa B Proteins; In Situ Nick-End Labeling; NF-kappa B; Protein Transport; Pyrazoles; Signal Transduction; Sulfonamides; Tetrazolium Salts; Thiazoles; Tumor Necrosis Factor-alpha | 2012 |
Activation of Src induces mitochondrial localisation of de2-7EGFR (EGFRvIII) in glioma cells: implications for glucose metabolism.
Topics: Cell Line, Tumor; Dasatinib; Endoplasmic Reticulum; ErbB Receptors; Extracellular Matrix Proteins; Glioblastoma; Glucose; Golgi Apparatus; Humans; Hydrogen-Ion Concentration; Mitochondria; Mutagenesis, Site-Directed; Oxygen Consumption; Phosphorylation; Protein Kinase Inhibitors; Pyrimidines; src-Family Kinases; Thiazoles; Transcriptional Activation; Transfection | 2011 |
Immunocytochemical studies on the effect of 405-nm low-power laser irradiation on human-derived A-172 glioblastoma cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Glioblastoma; Humans; Immunohistochemistry; Low-Level Light Therapy; Microscopy, Fluorescence; Necrosis; Tetrazolium Salts; Thiazoles | 2012 |
Growth inhibition of malignant glioblastoma by DING protein.
Topics: Animals; CDC2 Protein Kinase; Cell Cycle Checkpoints; Cell Line, Transformed; Cell Line, Tumor; Cell Proliferation; Cyclin B; Cyclin E; Cyclin-Dependent Kinases; DNA-Binding Proteins; E2F Transcription Factors; Endopeptidase K; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glioblastoma; Green Fluorescent Proteins; Humans; Hypericum; Mice; Plant Preparations; Polycomb Repressive Complex 1; Tetrazolium Salts; Thiazoles; Time Factors; Transfection; Ubiquitin-Protein Ligases | 2012 |
3-Bromopyruvate antagonizes effects of lactate and pyruvate, synergizes with citrate and exerts novel anti-glioma effects.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Cell Survival; Citric Acid; D-Amino-Acid Oxidase; Electrophoresis, Polyacrylamide Gel; Glioblastoma; Glioma; Glycolysis; Humans; Hydrogen Peroxide; Immunoblotting; Lactic Acid; Oxidative Stress; Pyruvates; Pyruvic Acid; Tetrazolium Salts; Thiazoles | 2012 |
The inhibitory effect of CIL-102 on the growth of human astrocytoma cells is mediated by the generation of reactive oxygen species and induction of ERK1/2 MAPK.
Topics: Antineoplastic Agents; Astrocytoma; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Central Nervous System Neoplasms; Enzyme Induction; Glioblastoma; Humans; Mitogen-Activated Protein Kinase Kinases; Quinolines; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles | 2012 |
REST controls self-renewal and tumorigenic competence of human glioblastoma cells.
Topics: Analysis of Variance; Animals; Annexin A5; Apoptosis; Blotting, Western; Cell Transformation, Neoplastic; Colorimetry; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glioblastoma; Humans; Immunohistochemistry; In Vitro Techniques; Mice; Mice, SCID; MicroRNAs; Real-Time Polymerase Chain Reaction; Repressor Proteins; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2012 |
Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
Topics: Acetone; Antineoplastic Agents; Calorimetry, Differential Scanning; Cell Line, Tumor; Cell Survival; Coumarins; Drug Carriers; Endocytosis; Fluorescent Dyes; Glioblastoma; Humans; Lactic Acid; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Teniposide; Thiazoles | 2012 |
Active efflux of Dasatinib from the brain limits efficacy against murine glioblastoma: broad implications for the clinical use of molecularly targeted agents.
Topics: Acridines; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Blood-Brain Barrier; Brain; Dasatinib; Disease Models, Animal; Endothelium, Vascular; Glioblastoma; Humans; Mice; Mice, Knockout; Molecular Targeted Therapy; Oncogenes; Permeability; Pyrimidines; Signal Transduction; Survival Analysis; Tetrahydroisoquinolines; Thiazoles; Tight Junctions; Tissue Distribution; Treatment Outcome; Xenograft Model Antitumor Assays | 2012 |
PARP-1 inhibitors DPQ and PJ-34 negatively modulate proinflammatory commitment of human glioblastoma cells.
Topics: Anti-Inflammatory Agents; Biomarkers; Brain Neoplasms; Carnosine; Cell Line, Tumor; Cell Survival; Coloring Agents; Down-Regulation; Fluorescent Antibody Technique; Glioblastoma; Humans; Isoquinolines; L-Lactate Dehydrogenase; Microscopy, Confocal; Nitrites; Phenanthrenes; Piperidines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Tetrazolium Salts; Thiazoles; Trehalose | 2013 |
Fluorine-labeled dasatinib nanoformulations as targeted molecular imaging probes in a PDGFB-driven murine glioblastoma model.
Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Dasatinib; Disease Models, Animal; Fluorine Radioisotopes; Glioblastoma; Kaplan-Meier Estimate; Liposomes; Mice; Micelles; Molecular Targeted Therapy; Nanoconjugates; NIH 3T3 Cells; Positron-Emission Tomography; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Pyrimidines; Radioactive Tracers; Receptor, Platelet-Derived Growth Factor alpha; Signal Transduction; Thiazoles | 2012 |
Melanoma differentiation-associated 7 (interleukin 24) inhibits growth and enhances radiosensitivity of glioma cells in vitro and in vivo.
Topics: Acetylcysteine; Adenoviridae; Animals; Astrocytes; bcl-2-Associated X Protein; bcl-X Protein; Blotting, Western; Brain Neoplasms; Cell Division; Cell Line; Cell Line, Tumor; Cell Survival; Cells, Cultured; DNA Fragmentation; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Down-Regulation; Gene Transfer Techniques; Genes, Tumor Suppressor; Glioblastoma; Glioma; Glutathione Transferase; Humans; Interleukins; Necrosis; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Radiation-Sensitizing Agents; Rats; Rats, Inbred F344; Tetrazolium Salts; Thiazoles; Time Factors | 2003 |
Interferons upregulate thymidine phosphorylase expression via JAK-STAT-dependent transcriptional activation and mRNA stabilization in human glioblastoma cells.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Blotting, Western; Brain Neoplasms; Cell Line, Tumor; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Synergism; Fluorouracil; Glioblastoma; Half-Life; Humans; Indicators and Reagents; Interferons; Janus Kinase 1; Protein-Tyrosine Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA Processing, Post-Transcriptional; RNA, Messenger; STAT1 Transcription Factor; Tetrazolium Salts; Thiazoles; Thymidine Phosphorylase; Trans-Activators; Transcriptional Activation; Up-Regulation | 2005 |
Synthesis and in vitro cytotoxicity of haloderivatives of noscapine.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Glioblastoma; Humans; Indicators and Reagents; Kinetics; Noscapine; Tetrazolium Salts; Thiazoles | 2006 |
SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factor.
Topics: Angiogenesis Inhibitors; Cell Movement; Cell Proliferation; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Endothelial Cells; Glioblastoma; Humans; Neovascularization, Pathologic; Oxazoles; Protein Kinase Inhibitors; Thiazoles; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2007 |
Production of angiogenic factors by human glioblastoma cells following activation of the G-protein coupled formylpeptide receptor FPR.
Topics: Angiogenesis Inducing Agents; Animals; Cell Line, Tumor; Cell Proliferation; Corneal Surgery, Laser; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Interleukin-8; Mice; N-Formylmethionine Leucyl-Phenylalanine; Receptors, Formyl Peptide; Tetrazolium Salts; Thiazoles; Time Factors; Transplantation, Heterologous; Vascular Endothelial Growth Factor A | 2008 |
Structure-activity and high-content imaging analyses of novel tubulysins.
Topics: Animals; Cattle; Cell Line, Tumor; Depsipeptides; Glioblastoma; HeLa Cells; Humans; Mitosis; Oligopeptides; Structure-Activity Relationship; Thiazoles; Tubulin; Tubulin Modulators; Vinblastine | 2007 |
Lovastatin sensitized human glioblastoma cells to TRAIL-induced apoptosis.
Topics: Analysis of Variance; Anticholesteremic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Lovastatin; Receptors, TNF-Related Apoptosis-Inducing Ligand; Tetrazolium Salts; Thiazoles; TNF-Related Apoptosis-Inducing Ligand | 2008 |
Targeting the alpha 1 subunit of the sodium pump to combat glioblastoma cells.
Topics: Adenosine Triphosphate; Animals; Apoptosis Regulatory Proteins; Beclin-1; Brain; Calcium; Cardenolides; Cell Movement; Cell Proliferation; Cells, Cultured; Glioblastoma; Green Fluorescent Proteins; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Proteins; Sodium-Potassium-Exchanging ATPase; Statistics, Nonparametric; Tetrazolium Salts; Thiazoles; Transfection | 2008 |
Effect of selenium on malignant tumor cells of brain.
Topics: Animals; Anticarcinogenic Agents; Brain Neoplasms; Cell Death; Cell Division; Glioblastoma; Glioma; Humans; Rats; Selenium; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1995 |
O6-alkylguanine-DNA alkyltransferase activity of human malignant glioma and its clinical implications.
Topics: Astrocytoma; Brain Neoplasms; Combined Modality Therapy; DNA Damage; DNA Repair; DNA, Neoplasm; Drug Resistance; Enzyme Induction; Glioblastoma; Glioma; Humans; Methyltransferases; Neoplasm Proteins; Neoplasm Recurrence, Local; Nimustine; Nitrosourea Compounds; O(6)-Methylguanine-DNA Methyltransferase; Tetrazolium Salts; Thiazoles | 1994 |
Multidrug resistance in glioblastoma. Chemosensitivity testing and immunohistochemical demonstration of P-glycoprotein.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain Neoplasms; Carmustine; Cell Survival; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glioblastoma; Immunohistochemistry; Methotrexate; Mitoxantrone; Nimustine; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1998 |
Long recovery times improve the detection of cellular resistance in vitro.
Topics: Animals; Antineoplastic Agents; Cisplatin; Coloring Agents; Glioblastoma; Glioma; Humans; Rats; Rhabdomyosarcoma; Sensitivity and Specificity; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured | 1998 |
Polyoxoanions are cytotoxic to malignant glioma cells.
Topics: 3T3 Cells; Animals; Anions; Antineoplastic Agents; Brain Neoplasms; Cell Division; Cisplatin; Glioblastoma; Humans; Mice; Rats; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1998 |
Cytotoxicity, apoptosis, and viral replication in tumor cells treated with oncolytic ribonucleotide reductase-defective herpes simplex type 1 virus (hrR3) combined with ionizing radiation.
Topics: Apoptosis; Cell Survival; Combined Modality Therapy; Defective Viruses; Female; Flow Cytometry; Glioblastoma; Herpesvirus 1, Human; Humans; Pancreatic Neoplasms; Radiation Dosage; Radiation, Ionizing; Ribonucleotide Reductases; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Virus Replication | 2000 |
Identification of a peroxisome-proliferator-activated-receptor response element in the apolipoprotein E gene control region.
Topics: Animals; Apolipoproteins E; Astrocytoma; Base Sequence; Binding Sites; CCAAT-Enhancer-Binding Protein-beta; CCAAT-Enhancer-Binding Protein-delta; CCAAT-Enhancer-Binding Proteins; Cell Line; Consensus Sequence; DNA-Binding Proteins; Gene Expression Regulation; Glioblastoma; Introns; Luciferases; Macrophages; Microbodies; Molecular Sequence Data; Protein Biosynthesis; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; RNA, Messenger; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 2001 |
PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy.
Topics: Blotting, Western; Cell Cycle; Cell Line; Cell Nucleus; Cloning, Molecular; Coloring Agents; Cytoplasm; DNA Damage; Dose-Response Relationship, Drug; Down-Regulation; Etoposide; Genes, Reporter; Glioblastoma; Humans; Microscopy, Confocal; Mutation; Neoplasms; Nuclear Proteins; Phosphoric Monoester Hydrolases; Precipitin Tests; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; PTEN Phosphohydrolase; Retroviridae; Signal Transduction; Tetrazolium Salts; Thiazoles; Transcription, Genetic; Transduction, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2002 |
Expression of PPARgamma and its ligand-dependent growth inhibition in human brain tumor cell lines.
Topics: Antineoplastic Agents; Apoptosis; Astrocytoma; Blotting, Northern; Brain Neoplasms; Cell Division; Chromans; DNA; DNA Fragmentation; DNA, Complementary; Flow Cytometry; Glioblastoma; Humans; In Situ Nick-End Labeling; Ligands; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Troglitazone; Tumor Cells, Cultured | 2002 |
Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Death; Colorimetry; Drug Resistance; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Reproducibility of Results; Spectrophotometry; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1992 |